Skip to content

Tomography Positron Emission Assessment of the Impact of Cardiac Rehabilitation on Coronary Endothelial Function in Cardiac Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524574
Acronym
TEP-READ
Enrollment
54
Registered
2015-08-17
Start date
2010-09-30
Completion date
2015-11-30
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Failure

Brief summary

In patients with heart failure, the drive to the effort has demonstrated its safety and its interest. Patients with heart failure, endothelium-dependent peripheral vasodilatation is impaired by decreased activity of endothelial NO synthase. The rehabilitation training significantly improves peripheral endothelial function, and this improvement is correlated to the increase in exercise capacity. The impact on coronary endothelial function remains poorly documented, especially in non-ischemic dilated heart disease. The main objective of this study is to investigate the effectiveness of cardiac rehabilitation on the restoration of coronary endothelial function in cardiac failure patient evaluated with Tomography Positron Emission 15O-H2O.

Interventions

PROCEDUREcardiac Rehabilitation
OTHERTomography Positron Emission

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with heart failure with nonischemic dilated cardiomyopathy * Class II-III NYHA (New York Heart Association) * Having no contra-indication to the effort * Fraction Ejection ≤ 40% * patient who will have cardiac rehabilitation * Age over 18 years * informed consent signed * patient with a social security scheme

Exclusion criteria

* Hypertension\> 160/90 mmHg * High cholesterol level \> 6.0 mmol / l * Diabetes known and treated * Active smoking * Valvular heart disease, congenital or ischemic * Pregnant or breastfeeding women * Age \<18 years * Major Adult guardianship

Design outcomes

Primary

MeasureTime frame
Rate of myocardial blood flow during the cold testchange over baseline and after 3 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026